TSH (8432.TWO) monthly revenue, September 2026
TSH reported revenue of NT$0.33bn for September 2026, up 160.8% from the previous month and up 34.1% from a year earlier. Year-to-date revenue was NT$1.17bn, up 19.9% year on year. It ranked 38 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.
| Month | Revenue NT$bn | MoM % | YoY % |
|---|---|---|---|
| September 2026 | 0.33 | 160.8 | 34.1 |